GNC Introduces New Cannabidiol (CBD) Infused Products
PITTSBURGH, April 23, 2019 (GLOBE NEWSWIRE) — GNC Holdings Inc., a leading global health and wellness brand, announced that the company is now offering topical cream products containing cannabidiol (CBD), in select retail locations and online in 23 states and the District of Columbia.
By introducing 12 channel exclusive CBD products from Physician’s Grade, an innovative health and wellness company, and Myaderm, a manufacturer of advanced cannabinoid products, GNC expects to attract the growing customer base looking for innovative offerings in the CBD market.
The available Physician’s Grade products include the company’s face creams, luxe body lotion, scalp treatment and revitalizing shampoo. Myaderm’s offerings include their four popular topical creams, which are the CBD Body Cream, available in two sizes, the Double Strength CBD Body Cream and the CBD Sport Cream.
“As the market changes, GNC is committed to offering high-quality, innovative products that are being introduced in new categories like CBD,” said Ken Martindale, chairman and CEO of GNC. “We are excited to work with both companies to evolve our product mix and look forward to offering more CBD-infused beauty and skincare products in the future.”
Both Physician Grade and Myaderm topical products are now available in select GNC stores and online. To learn more about GNC’s CBD products, visit https://www.gnc.com/wellness/what-is-cbd.html.
GNC Holdings, Inc. (NYSE: GNC) is a global health and wellness brand that helps people live well. The company is known and trusted for quality performance and nutritional supplements, and its broad assortment features innovative private-label products as well as national recognized third-party brands, many of which are exclusive to GNC. GNC’s diversified, omni-channel business model has global reach and a well-recognized, trusted brand, and provides customers with excellent service, product knowledge and solutions. The company reaches consumers worldwide through company-owned retail locations, and domestic and international franchise activities, and e-commerce. GNC also has exceptional innovation and product development capabilities, manufactures products for third parties and generates revenue through corporate partnerships. As of December 31, 2018, GNC had approximately 8,400 locations, of which approximately 6,200 retail locations are in the United States (including approximately 2,200 Rite Aid licensed store-within-a-store locations) and franchise operations in approximately 50 countries.
About Physician’s Grade
Physician’s Grade is an innovative health and wellness company focused on bringing safe, effective products to the world so people can live more active, healthy lives. From the premium materials we source to the testing we perform and manufacturing designations we proudly hold with the FDA, we are hyper-focused on creating products that far exceed the marketplace.
Myaderm uses proven technologies to create innovative cannabinoid products that provide a clear benefit. The company produces pharmacist-formulated, transdermal Cannabidiol (CBD) creams and topical CBD products for skin care. All products are manufactured in an FDA-registered facility.
PITTSBURGH, April 23, 2019 (GLOBE NEWSWIRE) — GNC Holdings Inc., a leading global health and wellness brand, announced that the company is now offering…
GNC Has Officially Started Selling CBD Supplements
One of the most popular supplement chains is cashing in on the rise of CBD.
With over 4,500 stores in the United States and Canada, GNC is one of the largest retailers in the supplement world. That’s why it’s news that they’ve announced they’ve started selling cannabidiol (CBD) supplements.
The compound was outright illegal until Congress legalized industrial hemp just last year, but even though the FDA has yet to specify lawful pathways for products that contain CBD, that hasn’t stopped countless companies from launching CBD-based products at an extraordinary rate.
Twelve of them have been introduced to GNC’s line, which includes topical creams and shampoos from Physician’s Grade and Myaderm. No mention has been made of whether they’ll be providing CBD products that can be inhaled or consumed.
Why all the hype over CBD? It’s a powerful antioxidant that appears to help with inflammation, even when applied topically. Given its history as an illegal substance it’s been hard to build a wealth of studies, but research has suggested that CBD can be a powerful method of fighting inflammation, reducing pain, and possibly improving sleep and reducing anxiety.(1)(2)(3)(4)(5)(6)(7)
When it comes to topical ointments, rodent studies have found that it can alleviate symptoms of arthritis.(3)(8) Why the CBD shampoo, though? The companies claim that it may help to improve hair density, but research is lacking in that area.
“There’s more evidence that it can exert anti-inflammatory effects on the scalp and help with cell regeneration,” says Austin Katz, the founder of Shea Brand, which produces CBD-based products. “Both CB1 one and CB2 receptors are found in hair follicles. What’s cool is that it’s not pro growth or anti-growth; it’s simply regulatory.”(9)
[Don’t miss our complete guide to the benefits of CBD for athletes.]
The market seems to agree that GNC has made a smart move — their shares increased in value by about 13 percent after the announcement. The products are available at GNC now.
Featured image via ElRoi/Shutterstock
1. Klauke AL, et al. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol. 2014 Apr;24(4):608-20.
2. Woodhams SG, et al. The role of the endocannabinoid system in pain. Handb Exp Pharmacol. 2015;227:119-43.
3. Philpott HT, et al. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017 Dec;158(12):2442-2451.
4. Petrosino S, et al. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. J Pharmacol Exp Ther. 2018 Jun;365(3):652-663.
5. Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series. Send to Perm J. 2019;23:18-041.
6. Zuardi AW, et al. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol. 1993 Jan;7(1 Suppl):82-8.
7. Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011 May;36(6):1219-26.
8. Hammell DC, et al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016 Jul;20(6):936-48.
9. Telek A, et al. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J. 2007 Nov;21(13):3534-41.
One of the biggest supplement chains on Earth is officially going forward with CBD products, although they're shying away from inhalants.